HSP90AA1 and neoplasm: This association was confirmed in the present study, which showed that increased (>40% positive tumor cells) Hsp90α/β protein expression in locally advanced and metastatic pCRC correlated with reduced PFS and shortened OS independent of other clinicopathological prognostic factors.